Ftse Mib
34.475,55
0,04%
DAX
18.691,32
0,05%
S&P 500
5.267,84
-0,74%
NASDAQ
16.736,03
-0,39%
Bitcoin
67.589,58
-2,19%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adaptive Biotechnologies Corporation (ADPT) Adaptive Biotechnologies Corporation (ADPT) Notizie

ADPT

Adaptive Biotechnologies (ADPT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ADPT
DataOraFonteTitoloSimboloCompagnia
18/05/202400:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
07/05/202422:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADPTAdaptive Biotechnologies Corporation
07/05/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADPTAdaptive Biotechnologies Corporation
07/05/202422:05GlobeNewswire Inc.Adaptive Biotechnologies Reports First Quarter 2024 Financial ResultsNASDAQ:ADPTAdaptive Biotechnologies Corporation
17/04/202422:05GlobeNewswire Inc.Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:ADPTAdaptive Biotechnologies Corporation
02/04/202422:05GlobeNewswire Inc.Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 RevenueNASDAQ:ADPTAdaptive Biotechnologies Corporation
27/03/202413:30GlobeNewswire Inc.Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024NASDAQ:ADPTAdaptive Biotechnologies Corporation
07/03/202401:38Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
22/02/202422:05GlobeNewswire Inc.Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare ConferenceNASDAQ:ADPTAdaptive Biotechnologies Corporation
14/02/202422:05GlobeNewswire Inc.Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ADPTAdaptive Biotechnologies Corporation
29/01/202422:05GlobeNewswire Inc.Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024NASDAQ:ADPTAdaptive Biotechnologies Corporation
29/01/202422:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ADPTAdaptive Biotechnologies Corporation
27/12/202322:05GlobeNewswire Inc.Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ADPTAdaptive Biotechnologies Corporation
09/12/202314:30GlobeNewswire Inc.Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual MeetingNASDAQ:ADPTAdaptive Biotechnologies Corporation
05/12/202313:30GlobeNewswire Inc.Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual MeetingNASDAQ:ADPTAdaptive Biotechnologies Corporation
09/11/202322:05GlobeNewswire Inc.Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADPTAdaptive Biotechnologies Corporation
07/11/202313:30GlobeNewswire Inc.Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ® Assay Across BeiGene’s Lymphoid Malignancy PipelineNASDAQ:ADPTAdaptive Biotechnologies Corporation
02/11/202321:05GlobeNewswire Inc.Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023NASDAQ:ADPTAdaptive Biotechnologies Corporation
13/09/202313:30GlobeNewswire Inc.Adaptive Announces Launch of Epic Integration for clonoSEQ®NASDAQ:ADPTAdaptive Biotechnologies Corporation
30/08/202322:30GlobeNewswire Inc.Adaptive Biotechnologies to Participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:ADPTAdaptive Biotechnologies Corporation
08/08/202323:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
02/08/202322:05GlobeNewswire Inc.Adaptive Biotechnologies Reports Second Quarter 2023 Financial ResultsNASDAQ:ADPTAdaptive Biotechnologies Corporation
10/07/202322:05GlobeNewswire Inc.Adaptive Biotechnologies to Report Second Quarter Financial Results on August 2, 2023NASDAQ:ADPTAdaptive Biotechnologies Corporation
21/06/202312:02Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ADPTAdaptive Biotechnologies Corporation
20/06/202323:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADPTAdaptive Biotechnologies Corporation
13/06/202322:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADPTAdaptive Biotechnologies Corporation
02/06/202313:34GlobeNewswire Inc.Adaptive Biotechnologies Highlights New Data at ASCO 2023 and EHA 2023 Underscoring the clonoSEQ® Assay’s Impact as a Standard for Minimal Residual Disease Assessment in Patients with Hematologic CancerNASDAQ:ADPTAdaptive Biotechnologies Corporation
24/05/202322:05GlobeNewswire Inc.Adaptive Biotechnologies to Participate in Upcoming June Investor ConferencesNASDAQ:ADPTAdaptive Biotechnologies Corporation
12/05/202314:00GlobeNewswire Inc.Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare ConferenceNASDAQ:ADPTAdaptive Biotechnologies Corporation
09/05/202313:30GlobeNewswire Inc.Adaptive Biotechnologies Announces FDA Acceptance of Genentech’s Investigational New Drug Application for the First Neoantigen-Directed T-Cell Therapy Product in OncologyNASDAQ:ADPTAdaptive Biotechnologies Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ADPT

La tua Cronologia

BIT
F05097
Vontobel
NASDAQ
VTWG
Vangard Russell 2000 Gro...
BINA
SUPERUSDT
SuperFarm
FX
UZSUSD
UZS vs US Dollar
COIN
XCADUST
XCAD Token
COIN
STARTUSD
NYSE
CUBI-D
Customers Bancorp
NASDAQ
NSCN
Netscreen
EU
ARGAB
Argan Domestic bond 1.01...
NASDAQ
XAIR
Beyond Air
DGFX
FLRUSDT
Flare Network
NYSE
FTEV.WS
FinTech Evolution Acquis...
BIT
P19KF1
BNP Paribas Issuance
POLO
GODZUSDT
CryptoGodz
LSE
BCSA
USOTC
FKRAF
Fishkars (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network